GABA-based evaluation of neurologic conditions: MR spectroscopy

American Journal of Neuroradiology

Volumn 34, Issue 2, 2013, Pages 259-265

  Levy, Lucien M ^a   Degnan, A J ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NEUROTRANSMITTER; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; ZOLPIDEM;

ALCOHOLISM; ANXIETY DISORDER; AUTISM; BIPOLAR DISORDER; CEREBROSPINAL FLUID; COGNITIVE THERAPY; DRUG DEPENDENCE; DRUG MECHANISM; EPILEPSY; FOCAL EPILEPSY; HUMAN; INSOMNIA; METABOLITE; MIGRAINE; MOOD DISORDER; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SCHIZOPHRENIA; SEIZURE; SLEEP DISORDER;

ANTIPSYCHOTIC AGENTS; BRAIN DISEASES; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEURAL INHIBITION;

EID: 84876196719     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2902     Document Type: Review

References (97)

1. Roberts E, Baxter CF. Metabolic studies of gamma-aminobutyric acid. Neurology 1958;8(suppl 1):77-78
2. Roberts E, Rothstein M, Baxter CF. Some metabolic studies of gamma-aminobutyric acid. Proc Soc Exp Biol Med 1958;97:796-802
3. Defelipe J. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell-surface molecules. Cerebral Cortex 1993;3:273-89
4. Chang L, Cloak CC, Ernst T. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry 2003;64(suppl 3):7-14 (Pubitemid 36389866)
5. Doelken MT, Hammen T, Bogner W, et al. Alterations of intracerebral gamma-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies. Epilepsia 2010;51:1477-82
6. Rothman DL, Petroff OA, Behar KL, et al. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A 1993;90:5662-66 (Pubitemid 23176221)
7. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol 1999;30:125-31 (Pubitemid 29281713)
8. Goto N, Yoshimura R, Moriya J, et al. Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study. Psychiatry Res 2010;182:53-57
9. Jensen JE, Frederick BD, Wang L, et al. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magn Reson Med 2005;54:783-88 (Pubitemid 41457048)
10. Jensen JE, Frederick Bde B, Renshaw PF. Grey and white matter GABAlevel differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed 2005;18:570-76 (Pubitemid 43013898)
11. Keltner JR, Wald LL, Frederick BD, et al. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn Reson Med 1997;37:366-71 (Pubitemid 27107961)
12. Choi C, Bhardwaj PP, Kalra S, et al. Measurement of GABA and contaminants in gray and white matter in human brain in vivo. Magn Reson Med 2007;58:27-33 (Pubitemid 47229914)
13. Choi IY, Lee SP, Shen J. In vivo single-shot three-dimensionally localized multiple quantum spectroscopy of GABA in the human brain with improved spectral selectivity. J Magn Reson 2005;172:9-16
14. Choi IY, Lee SP, Merkle H, et al. Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn Reson Med 2004;51:1115-21 (Pubitemid 38796995)
15. Snyder J, Hanstock CC, Wilman AH. Spectral editing of weakly coupled spins using variable flip angles in PRESS constant echo time difference spectroscopy: application to GABA. J Magn Reson 2009;200:245-50
16. Shen J. Slice-selective J-coupled coherence transfer using symmetric linear phase pulses: applications to localized GABA spectroscopy. J Magn Reson 2003;163:73-80
17. Waddell KW, Avison MJ, Joers JM, et al. A practical guide to robust detection ofGABAinhumanbrain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging 2007;25:1032-38. Epub 2007 Feb 2
18. Henry ME, Lauriat TL, Shanahan M, et al. Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson 2011;208:210-18
19. Ke Y, Cohen BM, Bang JY, et al. Assessment of GABA concentration inhumanbrain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res 2000;100:169-78
20. Ryner LN, Sorenson JA, Thomas MA. 3D localized 2D NMR-spectroscopy on an MRI scanner. J Magn Reson Series B 1995;107:126-37
21. Ryner LN, Sorenson JA, Thomas MA. Localized 2D J-resolved 1H MRspectroscopy: strong coupling effects in vitro and in vivo. Magn Reson Imaging 1995;13:853-69
22. Edden RA, Barker PB. Spatial effects in the detection of gammaaminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 2007;58:1276-82 (Pubitemid 350234215)
23. Edden RA, Barker PB. If J doesn't evolve, it won't J-resolve: J-PRESS with bandwidth-limited refocusing pulses. Magn Reson Med 2011;65:1509-14
24. Donahue MJ, Near J, Blicher JU, et al. Baseline GABA concentration and fMRI response. Neuroimage 2010; 53:392-98
25. Northoff G, Walter M, Schulte RF, et al. GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci 2007;10:1515-17 (Pubitemid 350175872)
26. Muthukumaraswamy SD, Edden RA, Jones DK, et al. Resting GABA concentration predicts peakgammafrequency andfMRIamplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A 2009;106:8356-61
27. Levy LM, Ziemann U, Chen R, et al. Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol 2002;52:755-61 (Pubitemid 35403185)
28. Yamamoto M, Takahashi S, Otsuki S, et al. GABA levels in cerebrospinal fluid of patients with epilepsy. Folia Psychiatr Neurol Jpn 1985;39:515-19
29. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005;65:1730-36
30. Peltola J, Kulmala P, Isojarvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000;55:46-50 (Pubitemid 30460996)
31. Stagg CJ, Lang B, Best JG, et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010;51:1898-901
32. Petroff OA, Rothman DL, Behar KL, et al. Low brain GABA level is associated with poor seizure control. Ann Neurol 1996;40:908-11 (Pubitemid 27044609)
33. Petroff OA, Hyder F, Rothman DL, et al. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology 2001;56:709-15 (Pubitemid 32240088)
34. Petroff OA, Behar KL, Rothman DL. New NMR measurements in epilepsy: measuring brain GABA in patients with complex partial seizures. Adv Neurol 1999;79:939-45
35. Simister RJ, McLean MA, Barker GJ, et al. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection. Epilepsy Res 2009;83:168-76
36. Simister RJ, McLean MA, Barker GJ, et al. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003;61:897-902 (Pubitemid 37248641)
37. Simister RJ, McLean MA, Barker GJ, et al. Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy. Epilepsy Res 2007;74:107-15 (Pubitemid 46667222)
38. Taki MM, Harada M, Mori K, et al. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI instrument. Neuroimage 2009;47:1207-14
39. Aasly J, Silfvenius H, Aas TC, et al. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res 1999;35:211-17 (Pubitemid 29298114)
40. Petroff OA, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995;13:1197-211
41. Petroff OA, Rothman DL, Behar KL, et al. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia 1995; 36:457-64
42. Levy LM, Levy-Reis I, Fujii M, et al. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 2005;62:970-74 (Pubitemid 40973459)
43. Dalakas MC, Fujii M, Li M, et al. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000; 55:1531-35
44. Dalakas MC, Li M, Fujii M, et al. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780-84 (Pubitemid 32845494)
45. Murinson BB, Butler M, Marfurt K, et al. Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 2004;63:2146-48 (Pubitemid 39636268)
46. Levy LM, Hallett M. Impaired brain GABA in focal dystonia. Ann Neurol 2002;51:93-101 (Pubitemid 34027981)
47. Quartarone A, Siebner HR, Rothwell JC. Task-specific hand dystonia: can too much plasticity be bad for you? Trends Neurosci 2006;29:192-99
48. Taylor M, Bhagwagar Z, Cowen PJ, et al. GABA and mood disorders. Psychol Med 2003;33:387-93 (Pubitemid 36442782)
49. Hasler G, van der Veen JW, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007;64:193-200 (Pubitemid 46220776)
50. Sanacora G, Mason GF, Rothman DL, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999;56:1043-47 (Pubitemid 29526389)
51. Bhagwagar Z, Wylezinska M, Jezzard P, et al. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 2008;11:255-60 (Pubitemid 351231824)
52. Cotter D, Landau S, Beasley C, et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002;51:377-86 (Pubitemid 34251175)
53. Berrettini WH, Nurnberger JI Jr, Hare TA, et al. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 1983;18:185-94 (Pubitemid 13139282)
54. Goddard AW, Mason GF, Almai A, et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001;58:556-61 (Pubitemid 32523735)
55. Goddard AW, Mason GF, Appel M, et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004;161:2186-93 (Pubitemid 39587282)
56. Pollack MH, Jensen JE, Simon NM, et al. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:739-43 (Pubitemid 351312374)
57. Hasler G, van der Veen JW, Grillon C, et al. Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 2010;167:1226-31
58. Hashimoto T, Bazmi HH, Mirnics K, et al. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 2008;165:479-89 (Pubitemid 351694291)
59. Yoon JH, Maddock RJ, Rokem A, et al. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 2010;30:3777-81
60. Tayoshi S, Nakataki M, Sumitani S, et al. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res 2010;117:83-91
61. Krystal JH, Staley J, Mason G, et al. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 2006;63:957-68 (Pubitemid 44330454)
62. Addolorato G, Caputo F, Capristo E, et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 2002; 37:504-08
63. Ticku MK. Alcohol and GABA-benzodiazepine receptor function. Ann Med 1990;22:241-46 (Pubitemid 20361861)
64. Behar KL, Rothman DL, Petersen KF, et al. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcoholdependent and hepatic encephalopathy patients. Am J Psychiatry 1999;156:952-54 (Pubitemid 29260355)
65. Mason GF, Petrakis IL, de Graaf RA, et al. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry 2006;59:85-93 (Pubitemid 43005239)
66. Mason G, Appel M, de Graaf R, et al. Brain GABA falls by 1 month of detoxification and remains low. Alcohol Clin Exp Res 2003;Suppl(27):56A
67. Ke Y, Streeter CC, Nassar LE, et al. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 2004;130:283-93 (Pubitemid 38595429)
68. Ke Y, Streeter CC, Yurgelun-Todd DA, et al. A J-resolved, two dimensional MRS study of brain GABA and NAA levels in cocaine dependent subjects-before and after treatment. In: Proceedings of the International Society of Magnetic Resonance in Medicine, May 7-13, 2001; Montreal, Quebec, Canada
69. Winkelman JW, Buxton OM, Jensen JE, et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep 2008;31:1499-506
70. Kakeda S, Korogi Y, Moriya J, et al. Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T. Psychiatry Res 2011;192:55-59
71. Kim SJ, Lyoo IK, Lee YS, et al. Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy. Sleep 2008;31:342-47 (Pubitemid 351536506)
72. Bigal ME, Hetherington H, Pan J, et al. Occipital levels of GABA are related to severe headaches in migraine. Neurology 2008;70:2078-80
73. Fatemi SH, Folsom TD, Reutiman TJ, et al. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 2009;8:64-69
74. Fatemi SH, Reutiman TJ, Folsom TD, et al. GABA(A) receptor down-regulation in brains of subjects with autism. J Autism Dev Disord 2009;39:223-30
75. Harada M, Taki MM, Nose A, et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3T instrument. J Autism Dev Disord 2011;41:447-54
76. Henkin RI, Levy LM, Lin CS. Taste and smell phantoms revealed by brain functional MRI (fMRI). J Comput Assist Tomogr 2000;24:106-23
77. Levy LM, Henkin RI. Brain gamma-aminobutyric acid levels are decreased in patients with phantageusia and phantosmia demonstrated by magnetic resonance spectroscopy. J Comput Assist Tomogr 2004;28:721-27 (Pubitemid 39488548)
78. Licata SC, Jensen JE, Penetar DM, et al. A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology (Berl) 2009;203:819-29. Epub 2009 Jan 6
79. Mattson RH, Petroff OA, Rothman D, et al. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurol Scand Suppl 1995;162:27-30
80. Petroff OA, Rothman DL, Behar KL, et al. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567-71 (Pubitemid 26422556)
81. Weber OM, Verhagen A, Duc CO, et al. Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging 1999;17:417-25 (Pubitemid 29180204)
82. Verhoeff NP, Petroff OA, Hyder F, et al. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS. Epilepsia 1999;40:1433-38 (Pubitemid 29471344)
83. Petroff OA, Rothman DL. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin. Mol Neurobiol 1998;16:97-121 (Pubitemid 28372727)
84. Mueller SG, Weber OM, Duc CO, et al. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Epilepsia 2001;42:29-40 (Pubitemid 32171481)
85. Kuzniecky R, Hetherington H, Ho S, et al. Topiramate increases cerebral GABA in healthy humans. Neurology 1998;51:627-29 (Pubitemid 28406359)
86. Moore CM, Wardrop M, deB Frederick B, et al. Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study. Psychopharmacology (Berl) 2006;188:236-43 (Pubitemid 44371161)
87. Petroff OA, Hyder F, Rothman DL, et al. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543-48 (Pubitemid 32322201)
88. Petroff OA, Hyder F, Mattson RH, et al. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 1999;52:473-78 (Pubitemid 29075590)
89. Shiah IS, Yatham LN, Gau YC, et al. Effect of lamotrigine on plasma GABA levels in healthy humans. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:419-23 (Pubitemid 36403732)
90. Kuzniecky R, Ho S, Pan J, et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368-72 (Pubitemid 34150909)
91. Petroff OA, Hyder F, Rothman DL, et al. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 2000;41:675-80 (Pubitemid 30390418)
92. Sanacora G, Mason GF, Rothman DL, et al. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002;159:663-65 (Pubitemid 34274953)
93. Bhagwagar Z, Wylezinska M, Taylor M, et al. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004;161:368-70 (Pubitemid 38419291)
94. Streeter CC, Whitfield TH, Owen L, et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med 2010;16:1145-52
95. Sanacora G, Gueorguieva R, Epperson CN, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004;61:705-13 (Pubitemid 38890805)
96. Manor D, Rothman DL, Mason GF, et al. The rate of turnover of cortical GABA from [1-C-13]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA). Neurochem Res 1996;21:1031-41
97. Dager SR, Corrigan NM, Richards TL, et al. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 2008;19:81-96